Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F9DQU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,433
Award facts
- Contract value 100% obligated
- $10,432.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,432.72 delivery order (Contract No. 4570584095) to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The order, issued on January 21, 2026, with an ultimate completion date of January 22, 2026, was structured as a firm fixed-price contract with no set-aside designation, indicating competitive award. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2031 that enables the supply of a broad range of pharmaceutical products and medical commodities to military healthcare programs worldwide.
Repatha is a prescription medication used for cholesterol management and cardiovascular disease prevention, representing part of the extensive pharmaceutical portfolio that AmerisourceBergen delivers to federal military and veteran healthcare systems. As a major pharmaceutical distributor and critical vendor in the federal medical procurement supply chain, AmerisourceBergen maintains significant contracts with the DLA for specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company's established track record of fulfilling federal healthcare requirements through competitive procurement demonstrates its capability to meet the specialized medical supply needs of the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9DQU?
SPE2DR26F9DQU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F9DQU worth?
The government has obligated $10,433 on SPE2DR26F9DQU.
Is contract SPE2DR26F9DQU an order under another contract?
Yes. SPE2DR26F9DQU is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DQU competed?
The extent of competition for SPE2DR26F9DQU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award